Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA

Oncotarget

Volumn 4, Issue 10, 2013, Pages 1856-1857

  Diaz, Luis A ^a   Sausen, Mark ^b   Fisher, George A ^c   Velculescu, Victor E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Personal Genome Diagnostics   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CIRCULATING TUMOR DNA; CRIZOTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL EXPANSION; CELL FREE SYSTEM; CELL SELECTION; CHROMOSOME ANALYSIS; COLORECTAL CANCER; DNA SEQUENCE; GENE LOCUS; GENE REARRANGEMENT; GENOME ANALYSIS; HUMAN; MUTATIONAL ANALYSIS; ONCOGENE K RAS; RECEPTOR BLOCKING; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84886745593     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1486     Document Type: Article

References (7)

1. Leary RJ et al. Science translational medicine 2012;4:162ra54.
2. Bardelli A et al. Cancer Discovery 2013;3(6):658-73.
3. Diaz LA Jr. et al. Nature 2012;486:537-40.
4. Engelman JA et al. Science 2007;316:1039-43.
5. Misale S et al. Nature 2012;486:532-6.
6. Ou SH et al. Journal of Thoracic Oncology 2011;6:942-6.
7. Comoglio PM et al. Nature Review Drug Discovery 2008;7(6):504-16.